Page last updated: 2024-08-25

n-methylscopolamine and silahexocyclium

n-methylscopolamine has been researched along with silahexocyclium in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brann, MR; Gdula, D; Wess, J1
Hanack, C; Herawi, M; Kopp, R; Lambrecht, G; Moser, U; Mutschler, E; Pfeiffer, A; Tacke, R1
Camus, J; Feifel, R; Lambrecht, G; Mutschler, E; Rafeiner, K; Rodrigues de Miranda, JF; Strohmann, C; Tacke, R; Tastenoy, M; Waelbroeck, M1

Other Studies

3 other study(ies) available for n-methylscopolamine and silahexocyclium

ArticleYear
Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
    Molecular pharmacology, 1992, Volume: 41, Issue:2

    Topics: Alkaloids; Amino Acid Sequence; Benzodiazepinones; Chimera; Dibenzazepines; Furans; Humans; Molecular Sequence Data; Muscarinic Antagonists; N-Methylscopolamine; Naphthalenes; Parasympatholytics; Piperazines; Piperidines; Receptors, Muscarinic; Scopolamine Derivatives; Sequence Homology, Nucleic Acid

1992
Human gastric mucosa expresses glandular M3 subtype of muscarinic receptors.
    Digestive diseases and sciences, 1990, Volume: 35, Issue:12

    Topics: Carbachol; Gastric Mucosa; Humans; In Vitro Techniques; N-Methylscopolamine; Parasympatholytics; Piperazines; Piperidines; Pirenzepine; Receptors, Muscarinic; Scopolamine Derivatives

1990
Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.
    British journal of pharmacology, 1994, Volume: 112, Issue:2

    Topics: Animals; Cattle; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; N-Methylscopolamine; Parasympatholytics; Piperazines; Pirenzepine; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Receptors, Muscarinic; Scopolamine Derivatives; Structure-Activity Relationship; Tumor Cells, Cultured; Vas Deferens

1994